ArticleFrontiers in oncology2022

Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma.

Long Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.